Cubist Pharmaceuticals Acquires Adynxx for Undisclosed Sum

  • Feed Type
  • Date
    2/25/2013
  • Company Name
    Adynxx
  • Mailing Address
    731 Market St. San Francisco, CA 94103
  • Company Description
    The company is dedicated to developing the next breakthrough therapeutic treatments for chronic pain.
  • Website
    http://www.adynxx.com
  • Transaction Type
    M&A
  • Transaction Amount
    Undisclosed
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Financial terms of the transaction were not disclosed by the parties.